Jazz Pharmaceuticals (JAZZ) Change in Receivables (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Change in Receivables of $6.5 million for Q1 2026, up 109.85% year-over-year from $3.1 million in Q1 2025, and down 90.12% quarter-over-quarter from $65.8 million in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Change in Receivables (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Change in Receivables history runs 17 years deep, the most recent figure standing at $6.5 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 109.85% year-over-year to $6.5 million; the TTM figure through Mar 2026 stood at $178.8 million (up 435.24% YoY), while the FY2025 annual figure was $106.3 million, up 403.33% from the prior year.
- Change in Receivables for Q1 2026 stood at $6.5 million, down from $65.8 million in the prior quarter.
- The five-year high for Change in Receivables was $75.5 million in Q4 2023, with the low at -$66.0 million in Q1 2025.
- The 5-year median for Change in Receivables is $9.7 million (2022), against an average of $16.2 million.
- Peak annual rise in Change in Receivables reached 7717.25% in 2025, while the deepest fall reached 881.71% in 2025.
- Jazz Pharmaceuticals' Change in Receivables stood at $46.3 million in 2022, then surged by 63.11% to $75.5 million in 2023, then tumbled by 101.14% to -$864000.0 in 2024, then jumped by 7717.25% to $65.8 million in 2025, then slumped by 90.12% to $6.5 million in 2026.
- Business Quant data shows JAZZ's Change in Receivables at $6.5 million in Q1 2026, $65.8 million in Q4 2025, and $51.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 44.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.90 Mn |
| Jun 30, 2026 | 44.90 Mn |
| Mar 31, 2026 | 6.50 Mn |
| Mar 31, 2026 | 6.50 Mn |
| Dec 31, 2025 | 65.81 Mn |
| Dec 31, 2025 | 65.81 Mn |
| Sep 30, 2025 | 51.00 Mn |
| Sep 30, 2025 | 51.00 Mn |
| Jun 30, 2025 | 55.47 Mn |
| Jun 30, 2025 | 55.47 Mn |
| Mar 31, 2025 | -66.00 Mn |
| Mar 31, 2025 | -66.00 Mn |
| Dec 31, 2024 | -864,000.00 |
| Dec 31, 2024 | -864,000.00 |
| Sep 30, 2024 | 22.26 Mn |
| Sep 30, 2024 | 22.26 Mn |
| Jun 30, 2024 | -8.72 Mn |
| Jun 30, 2024 | -8.72 Mn |
| Mar 31, 2024 | 8.44 Mn |
| Mar 31, 2024 | 8.44 Mn |